» Articles » PMID: 35681085

A Measure to Estimate the Risk of Imported COVID-19 Cases and Its Application for Evaluating Travel-related Control Measures

Overview
Journal Sci Rep
Specialty Science
Date 2022 Jun 10
PMID 35681085
Authors
Affiliations
Soon will be listed here.
Abstract

High connectivity between nations facilitates the spread of infectious diseases. We introduce an improved measure to estimate the risk of COVID-19 importation. The measure was applied to identify the effectiveness of travel-related control measures. We estimated the risk of importation, using the product of air-travel volume and COVID-19 prevalence in the area-of-origin. Travel volumes were acquired through real-time mobile data, and prevalence was calculated considering the time-varying strength of the COVID-19 testing policy. With the measure, the number of expected-imported cases was calculated, and compared with the reported-imported COVID-19 cases before and after post-entry quarantine for all entrants. The expected and reported-imported cases were well fitted (R = 0.8). A maximum of 35 undetected-imported cases was estimated to have entered Seoul, before the first imported COVID-19 case was confirmed. With the travel-related control measures, at most, 48 (73%) imported cases could be isolated from the local community. Our measure predicted trends in imported COVID-19 cases well. The method used to develop the measure can be applied to future emerging infectious diseases. Our results provide a 'real-world' evidence that travel-related control measures are effective at curbing further COVID-19 transmission.

Citing Articles

The impact of multiple non-pharmaceutical interventions for China-bound travel on domestic COVID-19 outbreaks.

Yang L, Hu M, Zeng H, Liang W, Zhu J Front Public Health. 2023; 11:1202996.

PMID: 37521963 PMC: 10373927. DOI: 10.3389/fpubh.2023.1202996.

References
1.
McAloon C, Collins A, Hunt K, Barber A, Byrne A, Butler F . Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research. BMJ Open. 2020; 10(8):e039652. PMC: 7430485. DOI: 10.1136/bmjopen-2020-039652. View

2.
Omori R, Mizumoto K, Nishiura H . Ascertainment rate of novel coronavirus disease (COVID-19) in Japan. Int J Infect Dis. 2020; 96:673-675. PMC: 7206424. DOI: 10.1016/j.ijid.2020.04.080. View

3.
Burns J, Movsisyan A, Stratil J, Biallas R, Coenen M, Emmert-Fees K . International travel-related control measures to contain the COVID-19 pandemic: a rapid review. Cochrane Database Syst Rev. 2021; 3:CD013717. PMC: 8406796. DOI: 10.1002/14651858.CD013717.pub2. View

4.
Lim J, Cho S, Ryu S, Pak S . Interpretation of the Basic and Effective Reproduction Number. J Prev Med Public Health. 2020; 53(6):405-408. PMC: 7733754. DOI: 10.3961/jpmph.20.288. View

5.
Kronbichler A, Kresse D, Yoon S, Lee K, Effenberger M, Shin J . Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis. Int J Infect Dis. 2020; 98:180-186. PMC: 7832751. DOI: 10.1016/j.ijid.2020.06.052. View